THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 33 filers reported holding THERAVANCE INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,740,000 | – | 3,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 41,771 | $44,921,000 | 2.37% |
| LINDEN ADVISORS LP | 45,495,000 | $48,853,000 | 1.16% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,759,000 | $5,092,000 | 0.94% |
| SSI INVESTMENT MANAGEMENT LLC | 6,850,000 | $7,332,000 | 0.60% |
| TEALWOOD ASSET MANAGEMENT INC | 1,390,000 | $1,492,000 | 0.59% |
| Castle Creek Arbitrage, LLC | 6,070,000 | $6,516,000 | 0.48% |
| OAKTREE CAPITAL MANAGEMENT LP | 21,717,000 | $23,355,000 | 0.37% |
| AQR Arbitrage LLC | 27,018,000 | $29,055,000 | 0.34% |
| CSS LLC/IL | 5,000,000 | $5,360,000 | 0.27% |
| CQS Cayman LP | 4,150,000 | $4,469,000 | 0.21% |